0.77
5.70%
0.0415
Dopo l'orario di chiusura:
.88
0.11
+14.29%
Precedente Chiudi:
$0.7285
Aprire:
$0.7235
Volume 24 ore:
1.56M
Relative Volume:
19.77
Capitalizzazione di mercato:
$13.78M
Reddito:
-
Utile/perdita netta:
$-26.56M
Rapporto P/E:
-1.0267
EPS:
-0.75
Flusso di cassa netto:
$-22.29M
1 W Prestazione:
-9.41%
1M Prestazione:
-16.15%
6M Prestazione:
-79.94%
1 anno Prestazione:
-75.04%
BiomX Inc Stock (PHGE) Company Profile
Nome
BiomX Inc
Settore
Industria
Telefono
972 7 23942377
Indirizzo
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
BiomX Inc Stock (PHGE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-04-15 | Iniziato | Ladenburg Thalmann | Buy |
BiomX Inc Borsa (PHGE) Ultime notizie
Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa
Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India
Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat
BiomX announces a mandatory unit separation - MSN
BiomX announces mandatory unit separation - Yahoo Finance
BiomX Announces a Mandatory Unit Separation - The Manila Times
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance
BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World
Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com
Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa
BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World
BiomX Shares Phage Therapy Advances and Vision - TipRanks
Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR
BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance
BiomX to present data from Phase 1b/2a study of BX004 - TipRanks
BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire
BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan
Biomx stock plunges to 52-week low, hits $1.05 - Investing.com
BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat
BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World
Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2024-2031: Enbiotix, Inc., Nextbiotics, - EIN News
BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
PHGEBiomX Inc. Latest Stock News & Market Updates - StockTitan
Biomx stock plunges to 52-week low at $1.15 amid market challenges - Investing.com
BiomX to Present Positive Phase 1b/2a Clinical Trial Data - GlobeNewswire
BiomX to present cinical trial data for BX004 at ERS - TipRanks
BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024 - StockTitan
Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Drops By 92.9% - MarketBeat
BiomX Inc (PHGE) stock analysis: A comprehensive overview - US Post News
Biomx stock plunges to 52-week low at $0.14 amid market challenges - Investing.com
There is no doubt that BiomX Inc (PHGE) ticks all the boxes. - SETE News
PHGE’s 2023 Market Dance: Down -44.29% – Time to Invest? - The InvestChronicle
Balance Sheet Insights: BiomX Inc (PHGE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
BiomX Inc (PHGE)’s highs and lows: A closer look at its stock price fluctuations - US Post News
BiomX (PHGE) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
BiomX (PHGE) 14-Day RSI : 28.12 (As of Aug. 18, 2024) - GuruFocus.com
BiomX (NYSEMKT:PHGE) Rating Reiterated by HC Wainwright - Defense World
BiomX (NYSEMKT:PHGE) Shares Scheduled to Reverse Split on Monday, August 26th - Defense World
BiomX announces reverse stock split effective August 26 By Investing.com - Investing.com Australia
BiomX shares maintain $2 target with Buy rating by H.C. Wainwright - Investing.com Canada
BiomX announces 1-for-10 reverse stock split - TipRanks
UPDATE ON UNITSBiomX Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewswire
Earnings call: BiomX reports Q2 2024 financials, clinical updates By Investing.com - Investing.com Australia
Earnings call: BiomX reports Q2 2024 financials, clinical updates - Investing.com
BiomX Inc. (AMEX:PHGE) Q2 2024 Earnings Call Transcript - Insider Monkey
BiomX Inc Inc. (PHGE) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Daily Progress: BiomX Inc (PHGE) Drop -11.58, Closing at 0.16 - The Dwinnex
BiomX announces reverse stock split effective August 26 - Investing.com
Biomx stock plunges to 52-week low, hitting $0.17 - Investing.com
BiomX Inc Azioni (PHGE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):